市場調查報告書

全球核酸等溫放大技術(INAAT)市場

Isothermal Nucleic Acid Amplification Technology (INAAT)

出版商 Global Industry Analysts, Inc. 商品編碼 907981
出版日期 內容資訊 英文 226 Pages
商品交期: 最快1-2個工作天內
價格
全球核酸等溫放大技術(INAAT)市場 Isothermal Nucleic Acid Amplification Technology (INAAT)
出版日期: 2020年09月01日內容資訊: 英文 226 Pages
簡介

本報告提供全球核酸等溫放大技術(INAAT)市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業等相關資訊。

第1章 調查方法

第2章 摘要整理

  • 市場概要
    • 核酸等溫放大技術(INAAT)市場的健全的成長
    • 競爭企業的市場佔有率
    • 全球市場佔有率方案
    • 各分類市場佔有率
    • 計量儀器
    • 試劑
  • 關注企業
  • 市場趨勢和促進因素
    • HIV,肝炎,其他感染疾病的發病率上升
    • 全球癌症發病率上升促進INAAT市場
    • 新的技術開發驅使市場擴大
    • 微流體實驗室晶片技術擴大在NAAT上POCT的使用
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 亞太地區
  • 其他地區

第4章 競爭

  • 榮研化學株式會社
  • LUCIGEN CORPORATION
  • MERIDIAN BIOSCIENCE
  • NUGEN AUDIO
  • QIAGEN GMBH
  • USTAR BIOTECHNOLOGIES (HANGZHOU) LTD.
  • BIOMeRIEUX SA

第5章 相關調查

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP12875

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Reach $4.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Isothermal Nucleic Acid Amplification Technology (INAAT) estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 10.4% over the analysis period 2020-2027. Infectious Diseases, one of the segments analyzed in the report, is projected to record a 11.1% CAGR and reach US$2.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Blood Screening segment is readjusted to a revised 10.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $642.4 Million, While China is Forecast to Grow at 9.7% CAGR

The Isothermal Nucleic Acid Amplification Technology (INAAT) market in the U.S. is estimated at US$642.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$745.7 Million by the year 2027 trailing a CAGR of 9.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.7% and 8.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Research Segment to Record 7.8% CAGR

In the global Research segment, USA, Canada, Japan, China and Europe will drive the 7.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$243 Million in the year 2020 will reach a projected size of US$412.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$501.4 Million by the year 2027.We bring years of research experience to this 5th edition of our report. The 226-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Becton, Dickinson and Company
  • bioMerieux SA
  • Eiken Chemical Co., Ltd.
  • Lucigen Corporation
  • Meridian Bioscience, Inc.
  • Nugen Audio
  • QIAGEN GmbH
  • Ustar Biotechnologies (Hangzhou) Ltd.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Witness Healthy Growth, Driven by Low-cost Advantages
    • Global Competitor Market Shares
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of HIV, Hepatitis, and Other Infectious Disease - A Key Factor Propelling the Need for INAAT
    • Global Incidence of HIV by Region: 2017
    • Rising Global Incidence of Cancer Drives the INAAT Market
    • Development of New Technologies to Propel Market Expansion
    • Microfluidic Lab-on-a-chip Technology Aids in Expanding NAAT Use to POCT
    • Global Hepatitis B Incidence and Mortality Rates
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 2: World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 3: World 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 5: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 6: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Blood Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 8: World Historic Review for Blood Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 9: World 15-Year Perspective for Blood Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 11: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 12: World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 14: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 15: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 17: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 18: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 20: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 21: World 15-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 23: World Historic Review for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 24: World 15-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 27: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 28: USA Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 29: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 30: USA 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 32: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 33: USA 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 34: USA Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 35: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 36: USA 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 37: Canada Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 38: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 39: Canada 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027
    • TABLE 40: Canada Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 41: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 42: Canada 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 43: Canada Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 44: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 45: Canada 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 46: Japan Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 47: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 48: Japan 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027
    • TABLE 49: Japan Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 50: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 51: Japan 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 52: Japan Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 53: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 54: Japan 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 55: China Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 56: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 57: China 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027
    • TABLE 58: China Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 59: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 60: China 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 61: China Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 62: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 63: China 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • Market Facts & Figures
    • European Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 64: Europe Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 65: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 66: Europe 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 67: Europe Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 68: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 69: Europe 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027
    • TABLE 70: Europe Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 71: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 72: Europe 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 73: Europe Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 74: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 75: Europe 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 76: France Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 77: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 78: France 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027
    • TABLE 79: France Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 80: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 81: France 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 82: France Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 83: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 84: France 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 85: Germany Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 86: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 87: Germany 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027
    • TABLE 88: Germany Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 89: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 90: Germany 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 91: Germany Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 92: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 93: Germany 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 94: Italy Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 95: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 96: Italy 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027
    • TABLE 97: Italy Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 98: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 99: Italy 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 100: Italy Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 101: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 102: Italy 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 103: UK Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 104: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 105: UK 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027
    • TABLE 106: UK Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 107: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 108: UK 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 109: UK Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 110: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 111: UK 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 112: Rest of Europe Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 113: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 114: Rest of Europe 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027
    • TABLE 115: Rest of Europe Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 116: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 117: Rest of Europe 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 118: Rest of Europe Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 119: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 120: Rest of Europe 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 121: Asia-Pacific Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 122: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 123: Asia-Pacific 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027
    • TABLE 124: Asia-Pacific Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 125: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 126: Asia-Pacific 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 127: Asia-Pacific Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 128: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 129: Asia-Pacific 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 130: Rest of World Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 131: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 132: Rest of World 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027
    • TABLE 133: Rest of World Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 134: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 135: Rest of World 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027
    • TABLE 136: Rest of World Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 137: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 138: Rest of World 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 46